Overview

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis

Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase 3 open-labeled study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of severe uveitis.
Phase:
Phase 3
Details
Lead Sponsor:
Sirion Therapeutics, Inc.
Treatments:
Difluprednate
Fluprednisolone